Articles:

Modulation of drug-induced apoptosis by interruption of the protein kinase C signal transduction pathway: a new therapeutic strategy

S Grant and WD Jarvis
Clin Cancer Res 1996 2: 1915 [PDF]  

A phase I and pharmacological study of topotecan infused over 30 minutes for five days in patients with refractory acute leukemia

EK Rowinsky, SH Kaufmann, SD Baker, CB Miller, SE Sartorius, MK Bowling, TL Chen, RC Donehower, and SD Gore
Clin Cancer Res 1996 2: 1921 [Abstract] [PDF]  

Treatment of recurrent malignant gliomas with high-dose 13-cis-retinoic acid

WK Yung, AP Kyritsis, MJ Gleason, and VA Levin
Clin Cancer Res 1996 2: 1931 [Abstract] [PDF]  

Possible prediction of adverse reactions to pyrimidine chemotherapy from urinary pyrimidine levels and a case of asymptomatic adult dihydropyrimidinuria

K Hayashi, K Kidouchi, S Sumi, M Mizokami, E Orito, K Kumada, R Ueda, and Y Wada
Clin Cancer Res 1996 2: 1937 [Abstract] [PDF]  

Irinotecan (CPT-11) metabolites in human bile and urine

F Lokiec, BM du Sorbier, and GJ Sanderink
Clin Cancer Res 1996 2: 1943 [Abstract] [PDF]  

Activation of human effector cells by a tumor reactive recombinant anti-ganglioside GD2 interleukin-2 fusion protein (ch14.18-IL2)

JA Hank, JE Surfus, J Gan, P Jaeger, SD Gillies, RA Reisfeld, and PM Sondel
Clin Cancer Res 1996 2: 1951 [Abstract] [PDF]  

d,l-buthionine-(S,R)-sulfoximine potentiates in vivo the therapeutic efficacy of doxorubicin against multidrug resistance protein-expressing tumors

U Vanhoefer, S Cao, H Minderman, K Toth, BS Skenderis, 2nd, ML Slovak, and YM Rustum
Clin Cancer Res 1996 2: 1961 [Abstract] [PDF]  

Interleukin 10 suppresses tumor growth and metastasis of human melanoma cells: potential inhibition of angiogenesis

S Huang, K Xie, CD Bucana, SE Ullrich, and M Bar-Eli
Clin Cancer Res 1996 2: 1969 [Abstract] [PDF]  

Analysis of MDR1 expression in normal and malignant endometrium by reverse transcription-polymerase chain reaction and immunohistochemistry

DY Kuo, S Mallick, HJ Shen, C DeVictoria, J Jones, AL Fields, GL Goldberg, CD Runowicz, and SB Horwitz
Clin Cancer Res 1996 2: 1981 [Abstract] [PDF]  

Preferential loss of expression of p16(INK4a) rather than p19(ARF) in breast cancer

AJ Brenner, A Paladugu, H Wang, OI Olopade, MH Dreyling, and CM Aldaz
Clin Cancer Res 1996 2: 1993 [Abstract] [PDF]  

Increased apoptosis accompanies neoplastic development in the human colorectum

FA Sinicrope, G Roddey, TJ McDonnell, Y Shen, KR Cleary, and LC Stephens
Clin Cancer Res 1996 2: 1999 [Abstract] [PDF]  

Validation of p53 accumulation as a predictor of distant metastasis at 10 years of follow-up in 1400 node-negative breast cancers

R Silvestrini, MG Daidone, E Benini, A Faranda, G Tomasic, P Boracchi, B Salvadori, and U Veronesi
Clin Cancer Res 1996 2: 2007 [Abstract] [PDF]  

bcl-2 and p53 expression in resectable pancreatic adenocarcinomas: association with clinical outcome

FA Sinicrope, DB Evans, SD Leach, KR Cleary, CJ Fenoglio, JJ Lee, and JL Abbruzzese
Clin Cancer Res 1996 2: 2015 [Abstract] [PDF]  

Telomerase activity in gynecological tumors

S Kyo, T Kanaya, H Ishikawa, H Ueno, and M Inoue
Clin Cancer Res 1996 2: 2023 [Abstract] [PDF]  

Identification of a variant estrogen receptor lacking exon 4 and its coexpression with wild-type estrogen receptor in ovarian carcinomas

W Park, JJ Choi, ES Hwang, and JH Lee
Clin Cancer Res 1996 2: 2029 [Abstract] [PDF]  

Regulation of insulin-like growth factor I receptor expression by the pure antiestrogen ICI 182780

H Huynh, T Nickerson, M Pollak, and X Yang
Clin Cancer Res 1996 2: 2037 [Abstract] [PDF]  

To see an article, click its [Full Text] or [PDF] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.